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Due to Earth’s changing climate, the ongoing and foreseeable spreading of
mycotoxigenic Aspergillus species has increased the possibility of mycotoxin
contamination in the feed and food production chain. These harmful mycotoxins have
aroused serious health and economic problems since their first appearance. The
most potent Aspergillus-derived mycotoxins include aflatoxins, ochratoxins, gliotoxin,
fumonisins, sterigmatocystin, and patulin. Some of them can be found in dairy products,
mainly in milk and cheese, as well as in fresh and especially in dried fruits and vegetables,
in nut products, typically in groundnuts, in oil seeds, in coffee beans, in different grain
products, like rice, wheat, barley, rye, and frequently in maize and, furthermore, even in
the liver of livestock fed by mycotoxin-contaminated forage. Though the mycotoxins
present in the feed and food chain are well documented, the human physiological
effects of mycotoxin exposure are not yet fully understood. It is known that mycotoxins
have nephrotoxic, genotoxic, teratogenic, carcinogenic, and cytotoxic properties and,
as a consequence, these toxins may cause liver carcinomas, renal dysfunctions, and
also immunosuppressed states. The deleterious physiological effects of mycotoxins on
humans are still a first-priority question. In food production and also in the case of
acute and chronic poisoning, there are possibilities to set suitable food safety measures
into operation to minimize the effects of mycotoxin contaminations. On the other
hand, preventive actions are always better, due to the multivariate nature of mycotoxin
exposures. In this review, the occurrence and toxicological features of major Aspergillus-
derived mycotoxins are summarized and, furthermore, the possibilities of treatments
in the medical practice to heal the deleterious consequences of acute and/or chronic
exposures are presented.
Keywords: mycotoxin, aflatoxins, ochratoxins, fumonisins, sterigmatocystin, food poisoning, carcinogenic,
secondary metabolites
INTRODUCTION
Each mycotoxin is a secondary metabolite produced by fungi, but not all secondary metabolites
are toxic (Bennett and Klich, 2003; Richard, 2007). Apart from mycotoxins, other secondary
metabolites are often produced by fungi, e.g., plant growth regulators, pharmaceutically useful
compounds, and pigments (Richard, 2007). These biological compounds usually play a part in
the survival of fungi and, concomitantly, are disadvantageous for their surroundings as well
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(Bennett and Klich, 2003; Keller, 2019). Various types of
environmental stress may trigger the production of these
deleterious compounds, suggesting their protective role,
e.g., under oxidative stress (Reverberi et al., 2010). Hence,
the production of mycotoxins may facilitate the successful
adaptation of fungi to a broad spectrum of environmental
stress conditions (Schmidt-Heydt et al., 2009), which are
raised, e.g., by the changing environment and climate (Van
der Fels-Klerx and Camenzuli, 2016; Medina et al., 2017).
Mycotoxin production may help fungi in competition with
other microorganisms (Hymery et al., 2014) or to resist against
grazing by insects (Rohlfs, 2015). In host – phytopathogenic
fungus interactions, mycotoxins may inhibit the germination of
seeds and may also contribute to the invasion of plant tissues
via eliciting versatile apoptotic and necrotic cell death processes
(Pusztahelyi et al., 2015).
Since 1962, when almost 100,000 turkeys died in an
unusual veterinary crisis in London, the field of mycotoxin
research has become a relevant scientific issue. That particular
“turkey X disease” was linked to peanut meals, which were
contaminated by aflatoxins (Sweeney and Dobson, 1998; Smith
et al., 2016). This specific new field of knowledge was
called mycotoxicology, which includes all areas of research
related to mycotoxins; meanwhile, the term mycotoxicosis
covers all animal and human diseases caused by mycotoxins.
Mycotoxins can be classified according to their chemical
structures, origin of biosynthesis, and characteristic symptoms
assigned to the particular toxins. In this paper, we aim at
summarizing the medical risks of consuming food contaminated
by Aspergillus-derived mycotoxins. Additionally, we included
a brief overview on some socioeconomic and environmental
impacts of mycotoxin food and feed contaminations, possibilities
for prevention, and the available decontamination methods and
medical treatments.
During the past 60 years, it has become clear that the world
has to deal with mycotoxin exposure (see Figure 1). Agricultural
commodities are often contaminated with mycotoxins, which
results in either visible, acute effects or chronic, long-term hidden
health damages (Souers et al., 2013; Smith et al., 2016; Udovicki
et al., 2018; Rushing and Selim, 2019). As maize, rice, and
wheat are among the most important crops, the presence of
mycotoxins in these feed and foodstuffs entails a high public
health risk of chronic exposure to mycotoxins (Jard et al., 2011;
Rodrigues et al., 2011; Smith et al., 2016; Udovicki et al., 2018).
The food shortage typical of mainly developing countries resulted
in necessary negligence of the mycotoxin content of food and
feed. The lack of knowledge about mycotoxins and their effects,
safety regulations and enforcement, infrastructure to monitor
and quantify the mycotoxin content, and the lack of political
will all contribute to mycotoxin exposures. These regrettable
circumstances led to the continuous risk of mycotoxin poisoning
and the worsening of living conditions in the affected regions,
especially in the case of children. Although mycotoxicoses mainly
occur in developing regions of the world, recent years showed
that industrialized countries in the moderate climate belt also
have to face the risks of Aspergillus-derived toxin exposure
(Cleveland et al., 2003; Udovicki et al., 2018). The occurrence
and spread of molds depend on several factors, including
environmental, social, and economic conditions (Omotayo et al.,
2019). Grain producers and exporters in the world encountered
the challenging problem of how mycotoxin contents in food
and feed should be somehow regulated (Cleveland et al., 2003;
EC 1881/2006, 2006; Udovicki et al., 2018). Although industrial
countries are mostly located in the moderate continental climate
belt and malnutrition is rare there, toxigenic Aspergillus species
are moving constantly north due to climate change (see
Figure 1; Battilani et al., 2016; Udovicki et al., 2018). Even
nowadays, mycotoxin contaminations and mycotoxicoses are
taken mainly as the problem of the Third World (Figure 1).
Africa, South America, and other tropical countries have already
been combating the ever-growing threat of mycotoxins for a long
time. Even there, the types and the amounts of mycotoxins in the
feed and food will be altered with the changing climate. To make
things even worse, non-prioritized toxins can also emerge as new
risks with unforeseeable effects and interactions. Unfortunately,
big nations, organizations, or countries, like the World Health
Organization (WHO), United States, China, or the European
Union (EU) have different limiting values for mycotoxins (EC
1881/2006, 2006; Marasas, 1995), which makes any concerted
actions by them quite difficult. During the last few years, several
economical, health, and agricultural studies opened the question:
what kind of pre- and post- harvest conditions and prevention
methods would be manageable and safe for human and animal
health (Shephard, 2008; Hamid et al., 2013; Mitchell et al., 2016)?
As humans are on the top of the food chain, accumulation
of mycotoxins clearly depends on animal consumption as well,
so feed contamination should also be taken into account and
thoroughly controlled. Nowadays, the globalization of food
production systems can easily lead to accidental exposures
of the consumers to multiple mycotoxins because (i) various
mold infestations can affect the same crop concomitantly, (ii)
additional infestations can occur during food processing, and
(iii) customers can buy and consume contaminated foodstuffs
bearing different mycotoxin contaminants. Importantly, all the
above events can be separated both spatially and temporally.
These palpable tendencies should raise the need for complex
analytical and interdisciplinary studies in the future, especially
when the changing climate represents a new global challenge
to the food production and food safety regulatory systems
(Gruber-Dorninger et al., 2019).
FOOD TOXICOLOGY AND MOLECULAR
MECHANISM OF MYCOTOXINS
Food toxicology is the field of science which deals with the
toxicological effects of food components (Hussein and Brasel,
2001). Not surprisingly, food and feed also contain the most
complex mixture of low-molecular-weight xenobiotics to which
humans and animals are exposed. Because of the growing amount
of evidence on the presence of mycotoxins in the feed and
food chain, food toxicology should be considered seriously as an
important discipline in combating mycotoxicoses (Shaw, 2014;
Dellafiora et al., 2018).
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FIGURE 1 | The risk of mycotoxin exposure. Milestones in mycotoxicology: (1) In 1962, mycotoxins are identified as cause of turkey “X” disease; (2) Aflatoxin
outbreak in Gambia in 1988, No. subjects: 391; (3) Aflatoxin poisoning in Egypt in 1992, No. subjects: 19; (4) Aflatoxin outbreak in Guinea in 1999, No. subjects:
approx. 600; and (5) Aflatoxin outbreak in Kenya 2004, No. subjects: approx. 100; (a) Due to the climate change and increasing mean temperature,
mycotoxin-producing fungi spread to the north. (b) Monoculture farming is sensitive to mold infestation. (c) Strict federal regulation can prevent the spread of mold.
(d) The strict regulation of import and export are important to minimalize mycotoxin contaminations. (e) Prevention of mycotoxin infestation is of primary importance.
Without sufficient education and up-to-date methods, it is hard to store, process, transport, or even analyze properly and safely food and feed. (f) Mycotoxins have
serious economic and financial consequences (see references in the text).
The dose – response relationship specifies the magnitude of
the response of an organism to exposure to a given chemical
stimulus after a certain exposure time. Acute mycotoxicoses
could be described with a rapid onset and a general response
(Marroquín-Cardona et al., 2014). The relationship between the
concentration of mycotoxins in food and the concentration of
toxicologically active substances at the site of action could be
characterized by toxicokinetics. The relationship between the
concentration of toxicants at the site of action and the toxic
effect at the level of molecules, tissues, or organs is determined
by toxicodynamics (Dellafiora et al., 2018). All Aspergillus
species can produce a wide range of mycotoxins, although each
species has one predominant, characteristic toxin in many cases
(Sweeney and Dobson, 1998). Because of the multivariate nature
of mycotoxins and their co-occurrence in food and feed, co-
ingested mycotoxins give rise usually to mixed symptoms coming
from additive and synergistic effects (Marroquín-Cardona et al.,
2014; Flores and González-Peñas, 2016; Dellafiora and Dall’Asta,
2017; Dellafiora et al., 2018). Brief toxicological aspects of
Aspergillus-derived mycotoxins are described in the following.
Aflatoxins
More than 20 types of aflatoxins (AFs) and their derivatives occur
in nature, but mainly four, B1, B2, G1, and G2, are proved to
be dangerous for humans and livestock (Wu et al., 2013; Smith
et al., 2016; Udovicki et al., 2018; Rushing and Selim, 2019).
AFs are furanocoumarins and are produced by various strains
of Aspergillus, including Aspergillus flavus, Aspergillus parasiticus,
Aspergillus nomius, and Aspergillus pseudotamarii as main AF
producers (Figure 2; Council for Agricultural Science and
Technology, 2003). Immunotoxic, carcinogenic, and mutagenic
effects are mainly attributed to the presence of the lactone ring
and the difuran ring (Vanhoutte et al., 2016). Aflatoxin B1 (AFB1)
is the most carcinogenic and best-studied AF. Aflatoxin M1
(AFM1) is the 4-hydroxy derivative of AFB1, formed in the liver
and excreted into the milk by the mammary glands of both
humans and lactating animals that have been fed with AFB1-
contaminated diet (Benkerroum, 2016; Cherkani-Hassani et al.,
2016; Alshannaq et al., 2017). As it is also excreted in the urine,
it is used frequently as a biomarker after AF exposure. AFB1
is metabolized in the liver by the cytochrome P450 enzyme
system (CYPs) and a potent carcinogen derivative is aflatoxin
B1-8,9-epoxide (AFB0), which has an exo and an endo isomer
(Rushing and Selim, 2019). Primarily, the CYP3A4 and CYP1A2
FIGURE 2 | Chemical structure of some carcinogenic aflatoxins.
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are responsible for AF biotransformation, and mainly the exo
isomer is formed, which has a highly electrophilic nature, perfect
for spontaneous reactions with biological amines in nucleic acids
and proteins (Rushing and Selim, 2019). In the case of DNA,
AFB0 binds covalently to the N7 position on guanine, forming
AFB1-N7-guanine adduct. The endo isomer has lower affinity
than the exo, so AFB1-exo-8,9-epoxide is thought to be the major
carcinogenic metabolite. Aflatoxicol (AFL) is the only metabolite
that could go through the placenta and which is formed by
the placenta itself. AFL is often found in the cytosolic fraction
of liver preparations and thought to be a reservoir for AFB1,
because it could be enzymatically converted back into AFB1,
using the cytosolic NADPH system. That mechanism could be
responsible for the AF-caused growth impairment, observed
mainly in developing countries (Rushing and Selim, 2019).
Acute aflatoxicosis results in death while chronic exposure
results in cancer, immunosuppression, and slowly manifesting
pathological conditions (Phillips et al., 2002; Dharumadurai
et al., 2011; Figure 4). Chronic aflatoxin poisoning leads to
impaired DNA duplication in the bone marrow, which causes low
leukocyte levels (Corrier, 1991; Fink-Gremmels, 1999; Benedict
et al., 2016), which in turn gives rise to immunodeficiency
and various infections. AFs also have a non-specific, cell
multiplication inhibiting effect on other cell types (Bennett and
Klich, 2003; Khlangwiset et al., 2011). This effect is the most
prominent in the gastrointestinal tract, where an intact cell cycle
is essential for the proper function of the digestive system (Liew
and Mohd-Redzwan, 2018). The lethal dose (LD50) values for AFs
are within the range of 0.5–10 mg/kg, depending on the chemistry
of the derivative (Hymery et al., 2014). The primarily affected
organ is the liver, and patients suffer from bile duct proliferation,
centrilobular necrosis, hepatic lesions, and fatty acid infiltration,
which often ends in liver cancer (Wu and Santella, 2012; Hymery
et al., 2014; Saha Turna and Wu, 2019).
The International Agency for Research on Cancer (IARC) has
classified aflatoxins, including AFB1, AFB2, AFG1, AFG2, and
AFM1 as carcinogenic to humans, i.e., as GROUP 1 carcinogens
(International Agency for Research on Cancer, 2012; Ostry et al.,
2017). AFs and the metabolites produced by the hepatic CYP
enzymes showed an interference with nucleotide pairing, which
can lead to different genetic changes, large-scale chromosomal
aberrations, or even to DNA strand breaks (Wild and Gong,
2009). The G→T transversion in codon 249 of the p53 gene
causing an Arg249Ser mutation on p53 protein is one of the
most common mutations found in human hepatocytes exposed
to AFB1. Arg249Ser mutation enhances cell growth and clonal
expansion and inhibits wild-type p53 activity and apoptosis
(Dumenco et al., 1995; Forrester et al., 1995; Rushing and Selim,
2019). Glutathione conjugation catalyzed by GST (glutathione-S-
transferase) of AFBO is a major route of detoxification, forming
an inert metabolite that is not able to react with the DNA
(Rushing and Selim, 2019). That conjugate is then converted into
a mercapturic acid adduct in vivo and is then excreted in the
urine (Moss et al., 1985; Rushing and Selim, 2019). Glutathione-
S-transferase expression is higher in mouse than in other animals,
which could be a reason why these rodents are more resistant
to AFB1 exposure.
Aflatoxins can also damage the hepatocytes directly or
through changing the expression of lipid metabolism connected
genes (Cpt1a, Lipc, Lcat, Scarb1, and Ahr). The elevated
cholesterol, triglyceride, and lipoprotein production can cause
the deterioration of hepatocytes because of the increased
metabolic need and anaerobic cell metabolism (Rotimi et al.,
2017). The elevated lipid fraction and the changed HDL–LDL
ratio in the blood can increase the possibility of coronary
heart diseases. The death of hepatocytes will lead to acute
hepatitis, which can cause liver failure and death or lower the
chance of survival (Hamid et al., 2013). Patients with hepatitis
have an impaired metabolism, which can result in malnutrition
(Nurul Adilah et al., 2018). The lack of nutrients also leads to the
depletion of reducing agents like glutathione and thus to the
overall reduction of antioxidative capacity in hepatocytes. In the
absence of nutrients, the hepatic tissue repair and regeneration
cannot function properly and the liver failure is almost inevitable
(Magnussen and Parsi, 2013).
Ochratoxins
Ochratoxin A (OTA) was first described in 1965, and it is
one of the most important mycotoxins (Heussner et al., 2015),
which is produced mainly by Aspergillus ochraceus, Aspergillus
carbonarius and Aspergillus niger as well as by Penicillium
verrucosum (Ostry et al., 2013; Bui-Klimke and Wu, 2015). OTA
is a pentaketide compound derived from a dihydrocoumarin
family derivative coupled to β-phenylalanine (Zhu et al., 2017).
IARC has classified OTA as a Group 2B carcinogen, which means
that it is possibly carcinogenic to humans. OTA has also been
reported as nephrotoxic, hepatotoxic, embryotoxic, teratogenic,
neurotoxic, immunotoxic, and genotoxic (Pfohl-Leszkowicz and
Manderville, 2007; Bui-Klimke and Wu, 2015). The symptoms
of OTA poisoning are dose-dependent, and its carcinogenic
properties are already well known in a variety of animal species.
The human aspects of OTA poisoning are not yet fully
understood, although OTA in humans can cause kidney damage,
cancer, or kidney failure, according to previous studies (Figure 4;
Heussner et al., 2015). A well-reported case was the so called
Balkan Endemic Nephropathy (BEN) (Barnes et al., 1977).
Several various human nephropathies reported in countries
as Bulgaria, Romania, Serbia, Croatia, Bosnia, Herzegovina,
Slovenia, Macedonia, and Montenegro could be related to
OTA (Reddy et al., 2010). African countries such as Congo,
South Africa, Tunisia, Morocco, and Egypt struggled with similar
cases. These effects of OTA were, however, not conclusive under
laboratory conditions. Both the monitoring of OTA and the
diagnosis of OTA-induced mycotoxicosis in humans rely on
blood and urinary OTA levels. The BEN cases could not be
related to the genetic background of the patients but, instead,
to environmental factors like the mold-contaminated local grain
(Pfohl-Leszkowicz and Manderville, 2007; Bui-Klimke and Wu,
2015). Surprisingly, chronic exposures to low OTA doses could
even be more harmful than acute high-dose exposures (Pfohl-
Leszkowicz and Manderville, 2007; Reddy et al., 2010). The
most frequent way of OTA exposure is dietary intake (Reddy
et al., 2010). Naturally and after biotransformation in the human
body, more than 20 OTA derivatives exist. Importantly, OTA
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forms covalent DNA adducts through radical and benzoquinone
intermediates. In addition, the OTA hydroquinone (OTHQ)
metabolite can undergo an autoxidative process to generate
the quinone electrophile OTA quinone (OTQ) that also reacts
with DNA. Furthermore, the formation of OTQ or phenoxy
and aryl radicals can result in increased reactive oxygen
species (ROS) production that is responsible for its cytotoxicity.
The mechanisms leading to OTA nephrotoxicity as well as
its hepatotoxicity and immunotoxicity can be linked to the
inhibition of protein synthesis, lipid peroxidation, and the
modulation of the MAP kinase cascade, in a way similar to the
exposure to pentachlorophenol derivatives (Heussner et al., 2015;
Malir et al., 2016; Zhu et al., 2017).
Emerging and Other Mycotoxins
Beside the toxins discussed above, Aspergillus species can also
produce other toxic compounds that are not in the focus of food
toxicology yet. They are, nonetheless, important and form an
emerging branch of mycotoxicology and are already the objects
of complex medical research projects in many cases.
Gliotoxin
Gliotoxin (GTX) is often referred to as a virulence factor. It is
produced mainly by Aspergillus fumigatus, although A. terreus,
A. flavus, and Aspergillus niger are also able to synthesize it
(Kwon-Chung and Sugui, 2008). GTX is a dipeptide and has
a disulfide bridge across the piperazine ring, being a member
of epipolythiodioxopiperazines (ETPs; Figure 3; Trown and
Bilello, 1972). This molecular feature could function in cross-
linking with cysteine residues in proteins, which results in the
generation of ROS through redox cycling reactions. The outcome
of these deleterious molecular processes is immunosuppression
and necrosis. GTX also alters the tight junction structures by
an unknown molecular mechanism and has a cytotoxic effect on
astrocytes (Patel et al., 2018).
Gliotoxin, like AFs, has an immunosuppressive effect, but the
molecular mechanism is different. GTX in lower concentrations
can inhibit the activation of inflammatory cells, the signaling
and communication pathways between the leukocytes, the
phagocytosis of macrophages, or the oxidative agent production
of neutrophils and macrophages (Figure 4; Corrier, 1991). In
higher concentrations (>250 ng/ml) GTX can induce apoptosis
in leukocytes (Lewis et al., 2005). The GTX-producing human
pathogenic fungi like A. fumigatus can evade the immunological
responses. Other immunodeficiencies, as AIDS, chronic steroid
treatment, alcohol abuse, and malnutrition can also be enhanced
by GTX poisoning.
Fumonisins
Fumonisins are a group of related polyketide-derived, non-
fluorescent mycotoxins. More than 53 different fumonisins have
been reported so far (Marasas, 1995; Månsson et al., 2010; Nair,
2017). They can be divided into four main series (A, B, C, and P)
but research has focused on the B series, mainly FB1, FB2, and
FB3, which are the most abundant in nature (Mogensen et al.,
2009). Fumonisin B compounds consist of a long hydroxylated
hydrocarbon chain, which are decorated by tricarballylic acid
and amino and methyl groups. FB2, FB3, and FB1 have different
hydroxylation patterns (Kouzi et al., 2018). Fumonisins are
structurally similar to cellular sphingolipids and, not surprisingly,
they have been shown to inhibit sphingolipid biosynthesis at
ceramide synthase (Marasas, 1995). The primary amino and
tricarballylic acid groups of the toxin are responsible for the
reaction with ceramide synthase. Fumonisin-induced toxicity
often results in apoptosis, alteration in cytokine expression, or
generation of oxidative stress (Kouzi et al., 2018). IARC has been
classified FB1 in toxicity Group 2B as probably carcinogenic for
people. Aspergillus species belonging to Aspergillus section Nigri
are widely occurring species, and one of them, A. niger, is a
highly important industrial organism in citric acid production.
Black Aspergilli including A. niger and A. welwitschiae can be
responsible for the FB2 (and FB4) contents observable in some
foods and feeds as grapes, raisins, wine (Mogensen et al., 2009,
2010), onions (Varga et al., 2012; Gherbawy et al., 2015), and
maize (Logrieco et al., 2014). However, Fusarium verticillioides,
Fusarium proliferatum, and other Fusarium spp. cause higher
fumonisin contaminations with FB1 (Frisvad et al., 2007; Kamle
et al., 2019). Co-occurrence of fumonisin producing Fusaria
and black Aspergilli in the kernels of maize may influence the
observed FB1/FB2 ratios (Logrieco et al., 2011; Susca et al., 2014).
Studies indicate that the fumonisins could be responsible for
esophageal cancer in South Africa and have been shown to cause
leukoencephalomalacia in horses and pulmonary edema in pigs
(Kouzi et al., 2018). Fumonisins are also responsible for other
diseases including neural tube defects, leukoencephalomalacia,
pulmonary edema, hepatotoxicity, nephrotoxicity, or renal
carcinogenesis (Nair, 2017; Figure 4). As sphingolipids are vital
in regulating various cellular processes and they are a large
family of metabolically linked signaling molecules, the acute and
chronic toxicities of fumonisins are the result of the disruption
of the sphingolipid metabolism and, as a result, the affected
organs are very diverse. Recent findings also showed increased
ROS production after fumonisin exposure, which may result
in DNA damage and other enzyme defects but more research
is needed to clarify the molecular backgrounds of these effects
(Kouzi et al., 2018).
Sterigmatocystin
More than 50 fungal species can produce sterigmatocystin (STC),
which, similar to AFs, is a polyketide mycotoxin. A. flavus,
A. parasiticus, and Aspergillus section Nidulantes, subclade
Versicolores are the most common source. Biosynthetic pathways
of AFs and STC share many biosynthetic enzymes (Díaz Nieto
et al., 2018). Since A. nidulans and A. versicolor are apparently
unable to biotransform STC into O-methylsterigmatocystin, the
direct precursor of AFB1 and AFG1, substrates colonized by these
fungi can contain high amounts of STC. On the other hand,
substrates invaded by A. flavus and A. parasiticus contain only
low amounts of STC as most of it is converted into AFs (EFSA,
2013). According to different animal models and cell culture
experiments, STC can also induce tumors; therefore, IARC
classifies it in the Group 2B as possible human carcinogen (EFSA,
2013). In spite of this classification, the maximum acceptable
levels of STC in food are not regulated worldwide. The acute oral
Frontiers in Microbiology | www.frontiersin.org 5 January 2020 | Volume 10 | Article 2908
fmicb-10-02908 December 21, 2019 Time: 15:51 # 6
Ráduly et al. Medical Aspects of Aspergillus-Derived Mycotoxins
FIGURE 3 | Chemical structures of ochratoxin A, patulin, gliotoxin, and fumonisins.
toxicity of STC is relatively low, with LD50 values varying between
120 and 166 mg/kg bw. After oral exposure, premalignant
and malignant lesions, such as hepatocellular carcinomas and
angiosarcomas in the brown fat, have been reported. STC is
genotoxic and carcinogenic, although the carcinogenic potency
of STC is approximately three orders of magnitude lower than
that of AFB1. STC is metabolized in the liver and lung by
various CYP enzymes into different hydroxy metabolites (Díaz
Nieto et al., 2018), and STC-metabolites are excreted in the
bile and the urine (EFSA, 2013). The mutagenicity of STC is
due to these reactive epoxi-adducts, which can covalently bind
to DNA and generate the STC-N7-guanine adducts. Another
mechanism was also proposed by Pfeiffer et al. (2014), who
suggested that the hydroxylation of the aromatic ring generates
a catechol, which could react with DNA. This was based on
the finding that in liver microsomes of humans and rats the
catechol was mainly formed while the epoxide was formed in
smaller amounts. Intensive research has been launched recently
on the role of STC in human esophageal and gastric cancers
(Figure 4). In vivo experiments were performed in a rat model
system, and these findings confirmed the conclusions previously
drawn from experiments on human-derived cell lines (Tong
et al., 2013; Díaz Nieto et al., 2018). It has been demonstrated
in a human immortalized bronchial epithelial cell line that STC
could induce DNA double-strand breaks, which may lead to
adenocarcinomas.
Patulin
Patulin (PAT) is produced by many different molds,
predominantly by Penicillium spp. (Puel et al., 2010; Frisvad,
2018; Vidal et al., 2019) but, occasionally, by some Byssochlamys
(Sant’Ana et al., 2010; Frisvad, 2018) and Aspergillus spp.,
including A. giganteus, A. longivesica, and A. clavatus (Varga
et al., 2007; Pal et al., 2017; Frisvad, 2018) as well. Chemically, PAT
is a water-soluble, colorless, polyketide lactone (Figure 3), which
is thought to exert its toxicity through reacting with thiol groups
(cysteine, glutathione, thiol moieties of proteins) in the cytoplasm
(Pal et al., 2017). In addition to its antibacterial, antiviral, and
antiprotozoal activities, PAT was also reclassified as a mycotoxin.
Because PAT also possesses acute toxicity, teratogenicity, and
mutagenicity properties at the same time (Puel et al., 2010),
the emerging symptoms of PAT mycotoxicoses are typically
non-specific but mostly connected to the enzyme inhibitions
(Pal et al., 2017). The affected enzymes usually take part
in digestion, metabolism, and energy production. Intestinal
disorders, decreased food intake, decreased weight, together
with altered lipid metabolism could be observed in many
animal models. PAT can also compromise the immune system
and modify the different response mechanisms of the host
(Corrier, 1991), and also inhibits transcription, translation, and
DNA synthesis in leukocytes (Mahfoud et al., 2002; Figure 4).
In vitro studies have demonstrated that PAT inhibits macrophage
functions like reduced rate of protein synthesis of lysosomal
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FIGURE 4 | Toxicological effects of mycotoxins in the human body.
Fumonisins can alter the sphingolipid metabolism, and it has an effect on the
membrane of different cells like neurons. Fumonisins may increase the
possibility of esophageal cancer formation. With different molecular pathways,
aflatoxin, gliotoxin, fumonisin, and patulin can suppress several immunological
mechanisms. Aflatoxins affect the pairing of nucleotides. Mutations of
proto-oncogenes or tumor suppressor genes can cause liver cancer. Aflatoxin
metabolites produced by the hepatic CYP enzymes can lead to chromosomal
DNA strand breaks. Aflatoxins can inhibit cell proliferation. In the gut,
mycotoxins can interfere with the regeneration of the gastrointestinal tract
forming cells. Gliotoxin can penetrate the blood–brain barrier, and due to its
cytotoxicity, it can damage the astrocytes. Sterigmatocystin may cause
esophageal cancer. Ochratoxin A is nephrotoxic and can cause kidney
damage, cancer, or renal failure. OTA was recently connected to Balkan
Endemic Nephropathy (BEN) kidney disease and chronic interstitial
nephropathy (for references, see the text).
enzymes and cytokines, altered membrane functions, and
significantly decreased ROS production, defects in phagosome–
lysosome fusion, and phagocytosis (Wichmann et al., 2002).
OCCURRENCE OF Aspergillus-DERIVED
MYCOTOXINS IN THE FEED AND FOOD
CHAIN
Several studies have been carried out in order to set appropriate
food safety regulations and recommendations (see Table 1).
These regulatory actions, however, must pursue reasonable trade-
offs to avoid unreasonable food wasting and to regulate trade
economic effects (Marroquín-Cardona et al., 2014; Dellafiora
et al., 2018). About 20–25% of the harvested fruits and vegetables
are lost due to various post-harvest diseases primarily caused
by molds even in developed countries, and this loss can even
be more severe in developing countries (Medeiros et al., 2012).
The average annual economic loss attributable to mycotoxin
contamination is about 1 billion USD in the United States alone
(Amaike and Keller, 2011). AFs are leading the list of the most
harmful mycotoxins when economic losses as well as agricultural
and health threats are considered and evaluated (Amaike and
Keller, 2011). The European Union (EU) Rapid Alert System for
Food and Feed (RASFF) was created in 1979, which is currently
based on the Regulation 178/2002 (European Parliament and of
the Council, 2002). The EU members can exchange information
on hazards in food through the Alarm System. Six types of
notifications are in use: alerts, information, information for
attention, information for follow-up, border rejections, and news;
however, the last one is not available for AFs. When a toxin-
containing food appears on the market, rapid action, like product
recall, is necessary and an alert notification is sent to RASFF as
well. Nearly 90% of the reported risks come from outside of the
EU (Figure 5); thus, border rejections are sent to all external
border posts of the EU to secure that the contaminated product
does not enter through other entry points (Pigłowski, 2018).
January 2009 the most commonly infected plants are cereal
crops, like maize and wheat, as well as cotton, soybean, and
different forms of nuts, especially groundnuts (Jelinek et al.,
1989; Dharumadurai et al., 2011). Fungal growth and toxin
contamination are the consequence of interactions among fungi,
the host, and the environment. As mentioned above, animals can
act as transmitting agents, as meat, milk, or eggs can pass AFs
to species in the food chain (Völkel et al., 2011; Figure 6). Food
processing can increase or decrease the concentration of AFs.
For instance, AFM1 is associated with protein fractions of the
milk. It is worth noting that AFM1 is heat-stable and binds to
casein and, hence, tends to accumulate in cheese (Sengun et al.,
2008; Busman et al., 2015; Benkerroum, 2016). Milk products
like different types of cheese can have three to five times higher
concentration compared to bulk milk, while butter or yogurt
processing can significantly decrease the concentration (Govaris
et al., 2001; Iha et al., 2013). Another group reported that
cocoa butter transmitted no infection from the originally infected
cocoa beans (Turcotte et al., 2013). Tropical and Mediterranean
climates facilitate the production of AFs, as toxin production
of A. flavus and A. parasiticus is reported between 28 and
35◦C (average, 30◦C), but some fungi stop the synthesis of
AFs above 36◦C (Table 2; Yu et al., 2008). These factors mean
that ingredients from these regions have higher risk of AFs
contamination (Battilani et al., 2016).
Not surprisingly, data for dietary intake of mycotoxins are
available in many countries for different age cohorts including
children and infants (Marin et al., 2013). The physiological
effects of mycotoxins and the assessed health risks for children
and infants are different from those of adults (Sherif et al.,
2009; Raiola et al., 2015). A recent study on Gambian infants
revealed an effect of AF exposure on the growth of infants
(Watson et al., 2018). Although further research is needed, AF
content of baby food might cause growth impairment in children.
Even though the WHO designated AFB1 and AFM1 as Class
1 carcinogens, some levels of consumption can be tolerated.
The safe content of the derivatives of AFs depends on the
foodstuffs. Limits in the EU are between 2 and 8 µg/kg AFB1
in foodstuffs dedicated for adults and 0.1 µg/kg AFB1 in baby
foods for infants and toddlers. Regarding AFM1, the limits are
lower, particularly 0.025µg/kg in dairy products, including infant
formula. The overall content of AFB1, AFB2, AFG1, and AFG2
in different foodstuffs is not allowed to be higher than 15 µg/kg
(EC 1881/2006, 2006). Risk assessment analysis indicated that
the hazard index for children under the age of 3 years was
considerably higher than that for adults, which supports the need
for more effective mycotoxin risk assessment and self-control
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TABLE 1 | Aspergillus-derived mycotoxins and Aspergillus spp. that produce them, high-risk foods, maximum levels in EU, FDA levels, and guidance values by WHO.
Mycotoxin Producing fungi High-risk foods EU Maximum Level FDA levels Guidance value
by WHO
Aflatoxins (AFB1, AFB2)
(AFG1, AFG2, AFM1)
A. flavus, A. parasiticus
A. parasiticus
Maize, wheat, barley and
other cereals, peanuts and
oil seeds, cottonseed,
coffee and cocoa beans,
figs and dried fruits, spices,
milk and dairy products
AFB1 2–8 µg/kg sum of
AFs 4 15 µg/kg AFM1
0.025–0.050 µg/kg baby
and infant foods
0.10 µg/kg
Foods 20 µg/kg Milk
0.5 µg/L
PTWI is not
established
Fumonisins (FB2, FB4) Predominantly
Fusarium-derived
mycotoxins, but also
produced by
A. welwitschiae and
A. niger
Maize, wheat, barley, rice,
millet, oats, coffee beans,
grapes
Unprocessed maize
4 mg/kg maize-based
foods 1 mg/kg cereals and
snacks 800 µg/kg baby
and infant foods 200 µg/kg
2–4 mg/kg PMTDI 2 µg/kg bw
Ochratoxin A (OTA) A. ochraceus, A.
carbonarius, A. niger
Maize, wheat, barley,
legumes, oil seeds,
peanuts, coffee beans,
cocoa beans, dried fruits,
grape juice and wine,
spices, meat products
Unprocessed cereals
3 µg/kg coffee beans
5 µg/kg dried fruit 10 µg/kg
juice and wine 2 µg/L dried
spices 15 µg/kg baby and
dietary foods 0.5 µg/kg
No level set (Mitchell
et al., 2016)
PTWI 112 ng/kg
bw
Patulin (PAT) Predominantly
Penicillium-derived
mycotoxin, occasionally
also produced by
A. clavatus infestation
of feed and food stuffs
Apples, grapes, many
fruits, juice, cider, tomatoes
Fruit juice and cider
50 µg/L baby foods
0.10 µg/kg
Apple juice 50 µg/L PMTDI 0.4 µg/kg
bw
Sterigmatocystin (STC) A. versicolor,
A. nidulans
Maize, wheat, peanuts, oil
seeds, coffee beans, milk
and dairy products
No data No data PTWI is not
established
Gliotoxin (GTX) A. fumigatus Cattle feed, mussel No data No data PTWI is not
established
PMTDI, provisional maximum tolerable daily intake; PTWI, provisional tolerable weekly intake. European Union (Regulation 1881/2006), US FDA–chemical contaminants,
metals, natural toxins, and pesticides guidance documents and regulations, JECFA–Joint FAO/WHO expert committee on food additives.
FIGURE 5 | Countries of origin for aflatoxin-related notifications in food based on the European Union (EU) Rapid Alert System for Food and Feed (RASFF) database
from 1st January 2009 until 27th June 2019 (European Parliament and of the Council, 2002).
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FIGURE 6 | Risk of mycotoxin exposure in the feed and food chain. Mycotoxins, like aflatoxins (e.g., AFB1), go through biotransformation in the livestock and
different metabolites are produced, such as AFM1, which can be excreted into the milk, where AFM1 can bind to casein. After digestion, AFM1 is released from the
casein – AFM1 complexes. The consumption of high amounts of dairy products contaminated with AFM1 can lead to acute mycotoxicosis (for references, see the
text). The carry-over rates of mycotoxins show seasonal differences, and there are other diverse factors influencing the prevalence of carry-over, e.g., the quantity of
mycotoxins in the feed and the excreted amount of toxin in the milk. The geographical location and feeding practice could also affect the carry-over rates, which
could be even 6%, regarding AFs (Völkel et al., 2011).
TABLE 2 | Growth conditions of some Aspergillus species and their optimum temperature for mycotoxin production.
Fungi Mycotoxins Growth
temperature
Optimal toxin production
temperature
Optimal
growth pH
Water activity References
A. flavus AFB1, AFB2 25–30◦C 28–35◦C 5–6 0.94–0.97 Lahouar et al., 2016; Stein and Bulboaca˘,
2017; Frisvad et al., 2019
A. parasiticus AFB1, AFB2,
AFG1, AFG2
15–33◦C 28–35◦C 5 0.95–0.99 Mannaa and Kim, 2017; Stein and Bulboaca˘,
2017; Frisvad et al., 2019
A. niger FB2 24–37◦C 25–30◦C 5 0.97–0.99 Mogensen et al., 2009; Passamani et al., 2014
A. versicolor STC 30◦C 23–29◦C 3.1–10.2 Min. 0.76 Veršilovskis and De Saeger, 2010; Stein and
Bulboaca˘, 2017
A. ochraceus OTA 24–37◦C 31◦C 3–10 Min. 0.8 Reddy et al., 2010
A. clavatus PAT 24–26◦C 25◦C 4.7 0.87 Zutz et al., 2013
A. fumigatus GTX under 42◦C 37◦C 7.35–7.45 0.92–0.97 Alonso et al., 2016
These representative data could be influenced by different environmental circumstances.
strategies in the milk industry (Farkas et al., 2014; Trevisani et al.,
2014; Kerekes et al., 2016; Ortiz et al., 2018).
The ochratoxins produced by strains of A. ochraceus,
A. carbonarius, and A. niger are often present together in food.
OTA can be found in a variety of agricultural products, especially
in cereals, grapes, and related products (Streit et al., 2012;
Tsitsigiannis et al., 2012). This mycotoxin occurs naturally and
is widespread around the world, but mainly in the Mediterranean
Basin, including Italy, Spain, and Greece (Covarelli et al., 2012;
Somma et al., 2012; Perrone et al., 2013; Arroyo-Manzanares
et al., 2019), and furthermore, in several African countries like
Cameroon, Senegal, Benin, and Nigeria (Rodrigues et al., 2011;
Tang et al., 2019). OTA can also be considered as a potentially
emerging mycotoxin in Central Europe due to the climate
change (Tóth et al., 2013; Pleadin et al., 2017; Udovicki et al.,
2018). The most common types of food bearing OTA are cereal
grains, oil seeds and tree nuts, wine, wine grapes and dried
fruits, spices, herbs and herbal teas, cocoa powder, and coffee
beans. Ochratoxins are food-borne mycotoxins, and this post-
harvest contamination can appear if crop-drying practices are
suboptimal and delayed (Reddy et al., 2010; Bui-Klimke and Wu,
2015). Analysis of several food and feed samples were performed
with enzyme immunoassays, which gave detection limits of 0.5 to
5 µg/kg. Intoxicated dry beans could bear 5–30 µg/kg, whereas
maize can bear 10–50 µg/kg, and green coffee beans contain 18–
48 µg/kg. Even as low as 0.16 µg/L and 0.24 µg/L of OTA could
be detected in South African white and red wines, where the
detection limit was above 0.01µg/L (Reddy et al., 2010). Ordinary
food processing is not able to eliminate or substantially reduce the
quantity of OTA in foods and beverages. Furthermore, processed
food products such as sausages and bread were also found to
contain OTA since it is a chemically very stable compound. The
EU set the maximum permissible levels of OTA in unprocessed
cereals at 3 µg/kg, in roasted coffee beans at 5 µg/kg, in
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dried fruits at 10 µg/kg, in fruit juice and wine at 2 µg/kg,
in dried spices at 15 µg/kg, and in dietary and baby foods at
0.5 µg/kg (EC 1881/2006, 2006). The United States Food and
Drug Administration (FDA) has not set maximum regulatory
limits for OTA in food (Mitchell et al., 2016). Based on a detailed
WHO risk assessment, including hazard identification, hazard
characterization, exposure assessment, and risk characterization,
the Joint Expert Committee on Food Additives (JECFA) issued
an official statement on OTA and have set provisional tolerable
weekly intake at 112 ng/kg bw, which was later rounded down
to 100 ng/kg bw. The limit was set based on various dose–
response studies on animals. The average weekly OTA intake
in Europe is 8–17 ng/kg bw, being well below the advised limit
(Bui-Klimke and Wu, 2015).
Patulin is produced by many different molds, which need
special, e.g., dirty, wet environments for spreading (Puel et al.,
2010; Ioi et al., 2017). Although mostly Penicillium spp. have
been isolated from food with PAT contamination in the moderate
climate belt, some recent studies have provided us with new
insights into PAT occurrence in food, which are mainly connected
to climate change. Inadequately stored cereals, e.g., under high
moisture conditions, can lead to the colonization by A. clavatus,
which is also responsible for the PAT contents of food in tropical
and sub-tropical regions. It is hard to estimate the contribution of
these molds to the PAT contents of foods and feeds precisely but
the role of Aspergillus spp. in global PAT exposures should not
be underestimated. Furthermore, A. clavatus may also colonize
malted barley and wheat, which might also contribute to the
appearance of PAT in the feed and food chain (Lopez-Diaz
and Flannigan, 1997; Loretti et al., 2003; Sabater-Vilar et al.,
2004). Different food products, like vegetables, rotting apples,
grains, and fruits may contain primarily Penicillium-derived
PAT (Puel et al., 2010; Wright, 2015; Frisvad, 2018; Vidal
et al., 2019). As this is a quite stable secondary metabolite, it
can withstand various harsh processing steps, such as milling
and heating. Apples and apple derivatives have the highest
concentration of PAT, and a maximum of 16 mg/kg has been
reported so far (Pal et al., 2017). Although the incidence of
PAT contamination is fairly high worldwide (Schatzmayr and
Streit, 2013) commercial apple juices normally contain less
than 10 µg/kg of PAT (Pal et al., 2017). Because PAT remains
stable during apple processing, PAT detection is often used as
a quality control parameter, indicating whether or not moldy
apple was processed (Karlovsky et al., 2016). During ethanol
fermentation, Saccharomyces cerevisiae can destroy PAT and,
hence, ciders and other fermented fruit drinks will not contain
this toxin (Yu et al., 2008), except when fresh fruit juice is
added to the cider after fermentation. Due to its toxicity and
potential harm to human health, according to JECFA, the
provisional maximum tolerable daily intake of PAT is 0.4 µg/kg
bw. PAT contaminations present in different food products are
mainly hazardous for special age cohorts, such as infants and
elderly people and also for gravidae. Since 2006, the European
Commission and China have set the maximum limit for PAT
to 50 µg/kg in fruits, while for products dedicated to younger
people, the limit has been set to 10 µg/kg (EC 1881/2006, 2006;
Ji et al., 2017).
Fumonisins are among the most significant agricultural toxin.
Although these mycotoxins are mainly produced by Fusarium
species, like F. verticillioides and F. proliferatum, this paper
focuses mostly on fumonisins produced by Aspergillus species
(Kamle et al., 2019). Fumonisins can cause serious loss to
agricultural production of cereals both in the field and during
storage and can be dangerous to animals and humans as well
(Mudili et al., 2014). It has been shown that A. niger can be
responsible for the presence of FB2 and FB4 (Varga et al., 2010).
Since grapes, wines, dried fruits, and grape-derived products have
a significant importance worldwide, the presence of A. niger
and A. welwitschiae in the global grape and wine production
chain has a high importance. When the temperature is below
30◦C, several molds are responsible for the observed varying
mycotoxin exposures, but when the temperature is higher than
37◦C, predominantly black Aspergilli are responsible for FB2
and FB4 contents of these foods and drinks. The spreading
of these species is even faster when the storing conditions are
not optimal, and physical damages on the berries also help
fungal invasion (Logrieco et al., 2011; Storari et al., 2012; Onami
et al., 2018). Other commonly infected food grains are maize,
wheat, barley, rice, millet, oats, and rye, but fumonisins are
present in coffee beans, too (Palencia et al., 2010; Varga et al.,
2010; Mudili et al., 2014). The most endangered species are
horses, pigs, and humans through direct ingestion. Importantly,
Mediterranean climate supports the spread of FB2 producer black
Aspergilli, as their optimum temperature for growth lies between
25 and 30◦C, with the upper and lower limits of 42 and 12◦C
(Mogensen et al., 2009).
Fumonisins are recognized by authorities and official limit
values have been issued. FDA has set the safe intake limit to
4000 µg/kg for food products containing whole maize grains
and 2000 µg/kg for products made with dried milled maize
products. Animal feed limits depend on the targeted animal, so
the limits can range from 5 to 100 mg/kg (FDA, 2001). JECFA
and the European Commission Scientific Committee for Food
have set the tolerable daily intake level of FB1, FB2, FB3, or their
combination at 2 µg/kg bw. The EU has defined the maximum
permissible levels for the sum of FB1+FB2 in unprocessed maize
at 4000 µg/kg, in maize-based foods at 1000 µg/kg, and in cereals
or snacks at 800 µg/kg. The maximum limit is 200 µg/kg in
processed foods for infants and toddlers (Commission of the
European Communities, 2006). Similar US regulations set 2000–
4000 µg/kg levels for the sum of FB1+FB2+FB3 depending on
the foodstuff (Bryła et al., 2017; Zhang et al., 2018).
Sterigmatocystin producing Aspergillus species, mostly
A. versicolor, infect mainly grains and grain products. Part of
the STC content in the food and feed are usually converted to
AFs by aflatoxigenic species, e.g., A. nidulans. The impact of
STC may appear smaller than AFs in the case of human intake,
but the importance of STC cannot be excluded (EFSA, 2013).
The occurrence of STC has been shown in cheese quite often
because AF-producing fungi are rarely present there. Previous
STC measurements in cheese found toxin levels from 5 to
600 µg/kg (Díaz Nieto et al., 2018). STC occurrence in spices
(fennel sample, red pepper, black pepper, and caraway seeds)
was also reported from African and Asian countries. For cereals,
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STC was reported in barley, wheat, rye, and oat, concentrations
being around 10–60 µg/kg from some European countries. As
traditional Chinese medicine is based on plants, STC was also
reported in these medicinal plant products, too. We cannot state
that STC occurrence in cheese is because of the feed as the rate
of carry-over of STC into milk when ruminants are exposed to
contaminated feed has not been inevitably proved. Moreover,
no information is available about the transfer of STC and/or its
metabolites into other animal products such as meat and eggs.
The exact toxicity of STC in livestock is not clear, as no signs
of toxicity were observed in sheep, when a feeding trial at the
highest dose were performed (16 mg/kg STC in feed, estimated
as equivalent to 0.3 mg/kg bw per day) (EFSA, 2013; Díaz
Nieto et al., 2018). As risk characterization is not possible for
STC, several international organizations recommend that more
accurate data for STC in food and feed across European countries
need to be collected. In case of food, methods with an LOQ
(limit of quantification) of less than 1.5 µg/kg should be applied,
whereas for feed, the available information is insufficient to
make a recommendation. The development of suitable certified
reference materials and/or proficiency tests to support analytical
methodology should be encouraged (EFSA, 2013; Díaz Nieto
et al., 2018). As the structure of STC and AFs are similar and
metabolites are often common, analytical method development
(immunoassays, isotope assays, etc.) and differentiation assays
are needed to differentiate between these mycotoxins.
PREVENTION STRATEGIES OF
MYCOTOXICOSES
Current possibilities for the treatment of mycotoxin poisoning
are still quite limited and are not specific. The best solution is,
therefore, to prevent mycotoxins to enter the feed and food chain
(Wagacha and Muthomi, 2008; Milic´evic´ et al., 2010; Kumar et al.,
2017; Ortiz et al., 2018; Arroyo-Manzanares et al., 2019). The
completely mycotoxin-free food and feed industry is, most likely,
an irrational goal but the minimization of mold infestations
and toxin deposition in the different agricultural products may
be possible and can effectively prevent mycotoxin poisoning
(Udomkun et al., 2017). It is important to state that the mold
infestation is not equal to mycotoxin contamination. But the
defense against all molds is favorable due to their effect on the
economy (Wu and Khlangwiset, 2010; Ehrlich, 2014).
Aspergillus species can enter the food and feed chain at
many stations of the industry (Gallo et al., 2015). The complex
production systems, climate change, economic processes, and the
resilience of the mycotoxins make it difficult to establish secure
prevention protocols, sampling methods, and an international
pipeline (Wild and Gong, 2009; Tasheva-Petkova et al., 2014;
Bandyopadhyay et al., 2016; Paterson et al., 2017). The diverse
factors that have an effect on the agricultural products can
be divided into two groups: the pre-harvest and post-harvest
circumstances (Jouany, 2007). Pre-harvesting factors include the
production of crops, growing conditions, and the prevention
of mold infestations in crops and other agricultural products
(Kabak et al., 2006). Masked mycotoxins may mount an even
greater risk to the consumers. It is well known that mold-
infected plants may alter the chemical structures of mycotoxins
as part of their defense mechanism against xenobiotics (Berthiller
et al., 2013). The modified mycotoxins can generate deposits
in the plant tissues and may remain hidden for conventional
analytics. These masked mycotoxins might pose additional
threats to human health and also represent further challenges to
both global food safety and the scientific community working
in this field. Obviously, to gain reliable and reproducible
data on the masked mycotoxins present in feed and food,
we need new analytical methods and also novel in vivo
experiments. To lessen the possibility of mycotoxin exposures,
it is important to raise awareness among the food- and feed-
producing countries with educational campaigns. There are
numerous options to lower the mycotoxin content of crops
before harvest (Sundh and Goettel, 2013; Mahuku et al., 2019).
Preventing mold infestations, limiting the spread of molds to
other plants, or neutralizing the mycotoxins already at pre-
harvest are all good examples and may hold great potentials.
Competitive but atoxigenic mold species and variants can
supersede toxin-producing Aspergillus species and, hence, are
suitable candidates in the elaboration of various biocontrol
strategies (Kagot et al., 2019). Large-scale monoculture farming
is highly prone to mold infestations, and this tendency may
strengthen further with changing climate. Cultivating more
diverse crop variants with different harvest dates on smaller
areas can effectively mitigate the risks of subsequent mold
infestations. There are possibilities to reduce the mycotoxin
production even if the mold infestation is present in crops
(Pfliegler et al., 2015). Co-cultivating the crops with genetically
modified plants or microorganisms might alter the chemical
structure of mycotoxins via changed metabolic pathways as part
of the defense against xenobiotics (Berthiller et al., 2013). Vitamin
C may regulate the genes of mycotoxin production, inhibiting
the expression of toxin-producing enzymes (Akbari Dana et al.,
2018). With polyculture farming on timed planting and with
modern methods like environmental stressors to prevent the
infestation, the economical and medical effects of the mold
contamination and mycotoxins could be minimized (Abramson
et al., 1997; Atehnkeng et al., 2014). Before the time of harvest,
an extensive examination of the crops should precede any other
procedures (Cleveland et al., 2003), since after harvest it is much
harder to reveal the contamination. The infected field should
be decontaminated by immediate harvesting and discarding the
contaminated crops to prevent further spreading.
The largest part of the threats is the post-harvest factors. These
include the harvesting criteria, the transporting circumstances,
the storage conditions before, and, after the processing steps, the
sampling methods, the inspections and toxin detection protocols,
and the international pipelines and regulations about the amount
of the mycotoxins contained in the foodstuffs (Zain, 2011).
The circumstances of storage are also crucial. Sorting before
the storage of crops is essential (Fandohan et al., 2005) since
in large storage facilities the mold infestation can spread more
easily between the different portions of the harvested crops (Hell
et al., 2000; Williams et al., 2014). On the other hand, the
correct cleanliness of the storage buildings is also critical (Adda
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et al., 2011), since if the storage conditions are not correct or
even favorable for the growing and spreading of mold, it could
lead to huge economical and financial losses or even medical
crises (Hussein and Brasel, 2001; Khlangwiset and Wu, 2010).
Inappropriately chosen storage parameters like concomitantly
high temperature and humidity can propagate mold infestations.
Therefore, ingredients should be dried and/or cooled to prevent
or at least limit fungal growth.
International pipelines and regulations have already been
put into operation to find the occurring mold infestation and
mycotoxin contamination as early as possible, but not everyone
keeps the rules. In the current ecological situation, the ingredients
of a product may come from all over the world. In the case
of such multifactorial systems, it is even more difficult to
control every aspect and, therefore, the ingredients should be
investigated individually.
If the mold infestation remained undetected and the
mycotoxin deposits are already formed, there are still possibilities
to lower the toxin levels (Yang et al., 2014; Udomkun et al.,
2017; Omotayo et al., 2019). Here, we outline the advantages
and disadvantages of some mycotoxin decontaminating methods
currently used in the agriculture and food industry and also
aim to evaluate some foreseeable future tendencies in this
field. Even though the toxins are heat-stable in a 150–200◦C
temperature range, their amount can still be lowered effectively
by heating (Herzallah et al., 2008). This amount of heat can
be problematic; in the case of heat-sensitive substances, the
administered heat has therefore to be limited. Because of the
remarkable heat stability of the Aspergillus-derived toxins and
the high thermal sensitivity of some valuable nutrients and
vitamins, any possibility for decontamination by heating should
be considered with care. Under mild conditions, the efficiency
of mycotoxin decomposition might be low because most
mycotoxins are heat-resistant within the range of usual food-
processing temperatures (80–121◦C) (Bullerman and Bianchini,
2007; Kabak, 2009; Karlovsky et al., 2016).
Ionized radiation produced by gamma rays can also be used
to lower the toxin levels (Ghanem et al., 2008; Jalili et al.,
2010). As the large-scale application of this technique, it is quite
difficult and it is usually applied as the last step in the food
production, when the commodities have already been packed.
In 2015, the International Atomic Energy Agency (IAEA) in
partnership with the Food and Agriculture Organization of the
United Nations (FAO) released the manual of good practice in
food irradiation aiming at improving food irradiation practices
worldwide, with a focus on developing countries (Di Stefano
and Pitonzo, 2014). The dose for package sterilization is set
between 10 and 20 kGy while the different foodstuffs like dried
materials or spices are irradiated with 30–50 Gy. Any overdosing
on gamma rays is contraindicated because it may induce the
degradation of valuable nutrients and the formation of other
toxic compounds. While this is a good method to lower the
toxin content, in the case of rural food production when the
crops are harvested for strictly personal use, it is not perfect.
However, portable food-irradiation machines are accessible,
although problems with financing and operating difficulties
limits their usage (Roberts, 2016). Although irradiation tools
may be quite complicated and may require a more advanced
technical background, irradiation may represent a reliable and
safe alternative for the decontamination of Aspergillus-derived
mycotoxins in the future. There is also a more complex side of
the reduction of mycotoxins by gamma irradiation. Especially
in the case of high starting toxin concentration, radiolytic
mycotoxin forms may be generated due to irradiation (Wang
et al., 2011; Yang, 2019). Although the toxicological effects of the
intact toxins and their radiolytic decomposition derivatives were
compared, the radiolytes had significantly less impact on human
health; the possible toxicological effects of the latter need further
investigations. In the future, the foreseeable increases in the
mycotoxin contents of different food commodities could bring
the effects of these radiolytic mycotoxin degradation products
into the spotlight.
Ozonation can also be an effective and reliable detoxification
method. In the case of ozonation, oxygen radicals are generated
through splitting of reactive ozone molecules, which then affect
different contaminants. The application of ozone can be in both
gas and liquid forms. One downside of this method is that the
effective ranges of these radicals are short, and, hence, they cannot
penetrate deeply into the different substances. The treatments
must be used on a large surface, which is only achievable in the
end of food production, just before the packaging. This protocol
has the same disadvantage as irradiation does, as it cannot be
applied on large quantities of foodstuff at the same time.
Besides physical toxin reductions, there are chemical
substances available to change the properties of the mycotoxins
and lower their physiological activities (Bryła et al., 2017).
These methods are very popular due to the fact that most of
the effective chemical components like citric, lactic, tartaric,
hydrochloric, succinic, acetic, and formic acids are already in use
in the food industry (Méndez-Albores et al., 2005, 2009; Wu and
Khlangwiset, 2010). The chemical treatment can be acidification,
ammonization, or ozonation (Karaca and Velioglu, 2014).
Every procedure can be accelerated with increased temperature;
otherwise, these methods would take days.
There are also biological methods to prevent and neutralize
mycotoxins in food and feed stuffs (Komala et al., 2012;
Quiles et al., 2015; Sultana et al., 2015). Biocontrol methods
can give rise to the most effective prevention techniques in
the future, and some methods have already been used with
promising results. These protocols use different biocontrol agents
(BCAs), which can modulate mycotoxin contaminations in
various ways. These agents can be different microorganisms
like other, atoxigenic but highly competitive, fungi, which can
limit the spreading of the mycotoxin producer strains. One
possibility is the inoculation of different microorganisms like
Lactobacillus or Saccharomyces into the toxin-contaminated
foodstuff (Tsitsigiannis et al., 2012). In addition, the application
of yeasts in various technological processes may have a direct
inhibitory effect on toxin production of certain molds, which is
independent of their growth suppressing effect (Pfliegler et al.,
2015). Other genetically modified BCAs can produce different
substances like Vitamin C, which can silence the gene clusters
responsible for mycotoxin productions. Furthermore, different
enzymes obtained from various Bacillus species showed high
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efficiency, but they have not been tested on a large scale. Plant
extracts with various enzymes might also be effective. The
different methods work synergistically, through the degradation
of the toxin, decreasing the active form of the mycotoxin or just
binding to the toxin and reducing the free toxin ratio. These
procedures are fairly effective, but their timescale is too long (48–
72 h) and the methods are difficult to apply on large quantities,
which mostly excludes them from industrial applications.
The combination of different methods can lead to reliable
protocols that can be used to reduce the mycotoxin levels in
the contaminated food and feed (Udomkun et al., 2017). The
combinations can also be effective in cases when the properties
of the target material limit the use of some toxin-decreasing
procedures. The detoxification methods are essential in the fight
against the mycotoxins but the wide array of toxin types and their
different effects and physical and chemical properties make it
difficult to find a universal solution (Omotayo et al., 2019). The
best solution is to minimize the occurrence of mycotoxins in the
food and feed industry.
MEDICAL ASPECTS OF
Aspergillus-DERIVED MYCOTOXINS
Despite prevention methods and strict regulations, mycotoxins
are still present in the feed and food chain, and the diseases
caused by dietary toxic fungal exposures are called mycotoxicoses
(Peraica et al., 1999). The processes of mycotoxin poisonings
have been partially cleared, but due to the multivariate nature
of the food and feed contaminations and to their not yet
fully understood metabolisms, the human side of poisoning
needs further investigations. The medical data presented here
are mainly acquired from large-scale toxin exposures as those
recorded in the acute poisoning outbreak in Kenya in 2004 with
125 deaths (Probst et al., 2007), in Tanzania during 2016 with
68 affected individuals, or in the former members of Yugoslavia
(Klaric´ et al., 2013). While the mycotoxins can enter the body
through the skin or the respiratory system, the most common
entry point is the gastrointestinal tract (Hedayati et al., 2007).
The manifested symptoms depend on the type and form of
digested mycotoxins, the amount of intake, the duration of
poisoning, age, sex, genetic background, and the health status of
the patients (Marroquín-Cardona et al., 2014; Dellafiora et al.,
2018; Keller, 2019). The absorption of the different forms of
the toxins depends on several factors (Gallo et al., 2015). In
the human body, the toxins undergo a detoxification process
and may form deposits mostly in the liver, but other tissues
could also store them. The mycotoxin derivatives formed in vivo
in humans and domestic animals may still have pathological
effects. As mentioned earlier, mycotoxins can have nephrotoxic,
genotoxic, teratogenic, carcinogenic, and cytotoxic properties but
are also capable of affecting tumor development due to their
antineoplastic potential (Pócsi et al., 2018).
Mycotoxicosis like most types of poisoning can be acute or
chronic. Acute poisoning has a rapid onset and characteristic
toxicity symptoms, like gastrointestinal discomfort, general
malaise and fatigue, or diarrhea due to the damage of the
enterocytes. Acute poisoning may occur when large quantities
of mycotoxin are consumed in a short period of time. The
incidence of acute mycotoxicosis is sporadic. In acute poisoning,
the type of mycotoxin exposure can change the mechanism of
the disease. The most frequent symptom being acute hepatitis
elicited by the toxins. The occurrence of mycotoxin-inflicted
hepatitis depends on many factors, e.g., Kwashiorkor, where
the resistance of the affected individual to harmful stressors
is generally decreased (Shephard, 2008). Other hepatotoxic
conditions such as viral hepatitis infections, heavy metals, or
alcohol and drug use can propagate the emergence of hepatitis
(Saha Turna and Wu, 2019). The chronic mycotoxin poisoning
is a worldwide problem. Compared to acute poisoning, the
incidence is higher, even so that not all chronic mycotoxicoses
are documented. Chronic poisoning is usually a consequence
of a low-dose exposure over a long time period, which might
result in irreversible effects such as neoplastic diseases (Wu
and Santella, 2012; Magnussen and Parsi, 2013). Several factors
influence the chronic toxicity of mycotoxins or the occurrence of
the first noticeable symptoms. These include the dosage, route of
exposure, and the overall health of the affected individual. During
chronic mycotoxin exposure, the effects are extensive. The
abovementioned basic molecular malfunctions are distinguished
but the clinical appearances are varied. The symptoms are slow
to appear and hard to connect to a specific disease. This is even
more difficult when the mycotoxin exposure is irregular, the
nutritional status is not stable, and other factors may alter the
overall medical status.
It is not easy to distinguish between acute and chronic
toxicities in mycotoxicoses because these diseases can easily be
mistaken for other common illnesses with similar symptoms.
The current understanding of Aspergillus-derived mycotoxins
still relies on some case studies (Smith et al., 2016; Udovicki et al.,
2018). There are possibilities to measure the mycotoxin levels in
the patient’s urine and blood, but without knowing any intake
ratio, it is hard to interpret these pieces of information (Escrivá
et al., 2017). Although there are some data recorded in larger
mycotoxin outbreaks in the third world, any connection between
the mycotoxin levels and the severity of the symptoms is difficult
to establish. On account of the individual differences, patients
with no detectable toxin levels showed symptoms, but these
findings could be the consequences of other unrelated diseases.
Furthermore, affected individuals with the same mycotoxin urine
concentrations had different symptoms (Peraica et al., 1999).
There is a well-documented case when a young woman tried, but
failed to commit suicide with purified AFB1 (Willis et al., 1980).
She took 5.5 mg of AFB1 over 2 days, and a half year later, a
total amount of 35 mg in a 2-week period. Different diagnostic
methods like X-ray and ultrasound of the liver or urine and blood
tests showed no pathological results throughout the years. The
lack of symptoms or any other abnormalities in physiological
parameters can be explained by her good physical condition and
nutritional status.
Combined Effects of Mycotoxins
Multiple mycotoxicoses may also occur because the human
diet is a complex mixture of various ingredients. Simultaneous
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spoiling of food by more than one toxigenic fungus has been
reported many times. Moreover, some fungi are able to produce
a broad spectrum of mycotoxins, and it is confirmed that
combined physiological effects of mycotoxins are as relevant
as the toxicity of a single mycotoxin. The harmful effects of
simultaneous exposures to mycotoxins cannot be predicted solely
relying on their individual toxicities. Additive, synergistic, or less
than additive toxic effects have been proven among different
mycotoxins. For example, interactions were shown between
OTA, AFs, and their metabolites in a dose-dependent manner,
and in lower concentration ranges, their effects were additive.
The explanation resides in the fact that both toxins affect
DNA pairing and duplication so they could induce carcinogenic
malformations. At higher concentrations, the combined effect
was less than additive, but it cannot be called antagonistic. The
different physiological effects were explained by the fact that AFs
and OTA went through the same bioactivation routes by CYP
enzymes in the liver; thus, the amount of bioactivated, potent
toxin forms was less compared to the separated experiments
(Klaric´ et al., 2013). Combined effects of AFs, OTA, and
fumonisins are “hot topics”, but ongoing and future research
should put more effort into the combinations of other emerging
mycotoxins as well.
In order to understand the combined effects of different
mycotoxins, researchers have developed various model systems.
Although these experiments are still in their infancy, we aim
at presenting some possible methods on how to analyze these
effects. Most of the combined mycotoxin tests were done using
binary or tertiary systems, and some of them are summarized
in Table 3. Intestinal cell lines (e.g., Caco-2 or IPEC-J2) or
gastric cell lines (e.g., NCI-N87) are widely used in cytotoxicity
and transportation assays because the first host defense barrier
against per os mycotoxin exposure is the gastrointestinal wall
(Wang et al., 2018; Assunção et al., 2019). In order to describe
the chronic-combined toxicological effects more accurately,
further experimental data are needed, where sub-toxic mycotoxin
concentrations should also be tested to simulate real food
consumption habits. Obviously, all in vitro studies have their
own limitations, but a 2- to 3-week-long mycotoxin treatment
may represent suitable models of organ-dependent toxicities.
Animal models are an efficient alternative to perform toxicity
experiments owing to the known genetic background and strictly
regulated diet (Alassane-Kpembi et al., 2017).
Although AFs, OTA, and FBs are all among those mycotoxins
that have been already regulated worldwide, a regulation of the
co-occurring different mycotoxins is still missing. This lack of
regulations could be explained by several factors. For example,
when a foodstuff is deemed to be contaminated by, e.g., AFs,
it is not analyzed further, so other contaminations may remain
hidden. However, this approach is favorable in terms of food
safety and is financially acceptable as well, because the AF-
affected food will be discarded anyway. The co-occurrence of
different mycotoxins could be the consequence of either pre-
harvest or post-harvest technologies. It has been shown that
AFs and OTA can be found together mainly in cereals but
herbs, spices, and dried fruits are also on the lists of potentially
contaminated foods (Almeida et al., 2012; Smith et al., 2016).
Furthermore, A. niger and A. carbonarius have been isolated
frequently from grapes grown in Australia, South America, or
Europe, and they are responsible for FB2 and OTA content
of grape wine (Logrieco et al., 2011; Storari et al., 2012), and
these two toxins could be responsible for several neoplastic
changes in humans.
However, to set a rational limit for combined mycotoxin
exposures, the exact concentrations of co-occurring mycotoxins
should be determined, even when the individual concentrations
are in the sub-toxic ranges. This will be an important goal
for further research in this field because people may consume
mycotoxins in sub-toxic concentrations without any detectable
symptoms, but the combinations of these sub-toxic exposures
may be deleterious (Anninou et al., 2014). An example for
chronic-combined effects of mycotoxins could be when they
TABLE 3 | Some representative combination of different mycotoxins and their interaction types.
Mycotoxin
couples
Doses Model system Exposure Interaction type Assays References
PAT + OTA PAT: 0.7–100 µM
OTA: 1–200 µM
Caco-2 cell line 24 h Synergism (Lower IC50 level) Less
than additive (High IC50 level)
MTT, TEER Assunção et al., 2019
AFB1 + OTA AFB1: 5–25 µM
OTA: 2.5–50 µM
Caco-2 cell line
and HepG2 cell
line
72 h Synergism and nearly additive (effects
were concentration dependent)
MTT Sobral et al., 2018
STC + OTA pM to µM Hep3B cell line 24–48 h Synergism and Less than additive
(Concentration ratio dependent)
MTT, SCE Anninou et al., 2014
STC + PAT PAT: 5–30 µM
STC: 0–35 µM
T. pyriformis 24 h Synergism and Less than additive
(Concentration ratio dependent)
Inhibition of cell
proliferation
Mueller et al., 2013
STC + GTX STC: 0–30 µM
GTX: 0–3.5 µM
T. pyriformis 24 h Synergism and Less than additive
(Concentration ratio dependent)
Inhibition of cell
proliferation
Mueller et al., 2013
PAT + GTX PAT: 5–30 µM
GTX: 0–3.5 µM
T. pyriformis 24 h Synergism Inhibition of cell
proliferation
Mueller et al., 2013
AFB1 + GTX AFB1: 0.5–128 µg/ml
GTX: 2–500 ng/ml
HCE cell line 24–72 h Synergism Cell impedance,
MTT
Bossou et al., 2017
TEER, transepithelial electrical resistance; SCE, sister chromatid exchange; MTT, cell viability assay.
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target the same physiological pathways. Complex biological
systems, like the immune system, where every aspect of
the mechanisms is essential and strictly regulated, are very
sensitive to multiple mycotoxin exposures. The production of
leukocytes could be impaired due to the genotoxic properties
of the mycotoxins and this can decelerate the division of
the progenitor cells and, furthermore, the function of the
differentiated leukocytes can also be inhibited. As some toxins
can negatively affect the protein synthesis of leukocytes, signaling
pathways, phagocytosis, and the differentiation of progenitors,
the overall result might be a large-scale immunosuppression.
The Risks of Mycotoxins at Different
Stages of Life
Mycotoxicosis can occur at every stages of life, and it can
affect the individuals differently according to their age. The
harmful effects of mycotoxins on cell division can lead to drastic
consequences, which are even more severe during intrauterine
life. There are some data on mycotoxicoses in children, infants,
and even in embryonic stage, but these topics definitely need
additional attention from the scientific community. Using human
embryonic stem cells (hESCs), a research group showed the dose
dependency of OTA toxicity (Erceg et al., 2019). More data could
give us a clearer view on how different mycotoxin exposures affect
the differentiation of hESC cells.
Mycotoxins mount variable challenges to humans at different
stages of life (Figure 7). They can influence the production
of gametes and thus the success of impregnation, because the
cytotoxic effect of the mycotoxins could hamper the division
and differentiation of the gametes and thus may cause infertility
by interfering with, e.g., spermatogenesis (El. Khoury et al.,
2019). Mycotoxins can damage the body of the mother, in the
abovementioned ways, and can cause nutrition deficit in the
embryo, but mycotoxins could also have more direct impacts.
AFL, a derivative of AFB1, can go through the placenta and
affect the embryo. This phenomenon was already documented
in humans, but the adverse effects of this has not yet been
fully investigated (IARC, 2015). From animal experiment, it is
known that mycotoxins can increase the possibility of stillborn
(Kanora and Maes, 2009). During lactation, AFM1 can also
be excreted within the breast milk. These circumstances show
the additional risks of mycotoxin poisoning in pregnant or
breastfeeding women (Ortiz et al., 2018; Rushing and Selim,
2019). According to the above, mycotoxin poisoning is a
significant risk to human development. The complex nature of
mycotoxicosis can cause various symptoms, which are mostly
connected to the cytotoxic and genotoxic properties of the
mycotoxins. In newborns and young children, the symptoms may
be more severe due to the fact that the mycotoxins like AFs
and OTA have a general negative effect on cell multiplication.
During development, the lack of adequate cell division may
lead to a delay or retention in growth, mental retardation, and
severe immunosuppression (Khlangwiset et al., 2011; Watson
et al., 2018). In vitro studies showed that GTX can alter the
connections between astrocytes and neurons, which could affect
the formation of the brain and ruin cognitive development (Patel
et al., 2018). As fumonisins inhibit sphingolipid biosynthesis, it is
cited as a possible cause of neuronal tube defects (Lumsangkul
et al., 2019). In children, the not yet fully developed and/or
damaged gastrointestinal tract cannot perform its task and the
pathways of nutrient absorption are compromised (Herrera et al.,
2019). Malnutrition is thus a well-known adverse factor in
mycotoxicosis since without sufficient nutrient intake, the body
cannot cope with the damage caused by the toxins or any other
external factors. Furthermore, the impaired digestive capability
makes the treatment even more difficult and less effective
(Lombard, 2014). For example, in developed countries, where
apple juice is a popular beverage among children, PAT content
of such soft drinks should be seriously regulated even though the
FIGURE 7 | The severity of consequences of mycotoxins in the different stages of life.
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long-term deleterious physiological effects of PAT have remained
yet to be fully understood (Pal et al., 2017). As mentioned earlier,
it is hard to distinguish between the effects of malnutrition
and mycotoxin exposures, although in the past two decades,
governments tried to put effort in a more thorough mycotoxin
monitoring. Blood, urine, and maternal milk specimens were
mostly analyzed for AFs, OTA, and FB1 (Chen et al., 2018). From
these data, the conclusion is that children are typically at high
risk under mycotoxin exposures. However, to get a better insight
into this matter, an international standard protocol should be
introduced (Al-Jaal et al., 2019).
Although healthy adults are endangered as well, their
detoxification system can usually handle an acute mycotoxin
exposure. However, different environmental factors, like drug
abuse, alcoholism, and malnutrition could act as a synergistic
factor in mycotoxicoses. In the case of chronic exposures in
adults, developmental disorders are not as significant as in
childhood. However, tissues where high cell division rate is
essential for their function are affected more by the harmful
mycotoxins. Hematopoiesis, the function of the enterocytes,
or the immune system requires sufficient cell-multiplication
where the xenobiotics, like mycotoxins, could have a drastic
impact on the cell cycle (Omotayo et al., 2019; Sobral et al.,
2019). It is undeniable that the carcinogenic properties of the
mycotoxins affect adults as well, and prolonged exposures may
cause complex neoplastic diseases (Alshannaq et al., 2017).
Throughout the aging process, the adaptive capabilities of the
body are decreasing, which could propagate the manifestation of
the abovementioned negative effects even earlier. These affected
individuals need a complex and life-saving therapy, e.g., liver
transplantations or immune therapies, which could take its toll
on the global health system.
Therapeutic Procedures
It is undeniable that mycotoxicoses represent a serious threat
to general health. The symptoms are treatable, although to
set appropriate differential diagnosis is quite difficult. When
investigating food poisoning, mycotoxins as the underlying factor
may usually emerge only when there are no other possibilities
left and all other contingencies such as viral gastrointestinal
infections or bacterial enterotoxins have been excluded. In acute
mycotoxin poisoning, the source of the exposure can easily
be recognized as the contaminated foodstuff can be analyzed
relatively easily and the given mycotoxin can be identified.
However, there are no specific and effective treatments for the
different mycotoxicoses until now (Hope, 2013). In the case of
acute poisonings, merely the symptoms are usually treated, but
these non-specific methods are rarely sufficient. The termination
of the exposure to mycotoxins and an appropriate diet could
better diminish the symptoms than any other medical procedure.
Nevertheless, below, we list the most commonly used current
methods to counteract mycotoxin poisonings (see also Figure 8).
Sequestering agents are non-absorbable materials that can
bind and neutralize mycotoxins in the gastrointestinal tract
(Phillips et al., 2002; Jard et al., 2011). These substances have
a large surface-to-volume ratio and, hence, they have a large
absorptive capacity. Activated carbon (charcoal) is a non-specific
FIGURE 8 | Possible target points for therapy.
absorbent, and it is a useful agent in multi-mycotoxin poisoning.
Clay is a widely studied material, especially in reducing the
toxicity of AFs. Novasil R© is a frequently studied agent and Phase
II clinical trials showed the safety of this material. It has been
shown that a 3-month-long treatment decreased the urinary
concentrations of AFB1 adducts and reduced the AFM1 level in
urine. Other trials were based on Novasil R© delivery in capsule,
in food, or added to water. Even a daily uptake of 3 g of this
absorbent is safe for adults, but a trial in Ghana showed that
0.75 g/day is safe even for children (Hope, 2013; Watson et al.,
2018). Cholestyramine (CSM) is an anion exchange resin and acts
as a bile sequestering agent. It could reduce the enterohepatic
recirculation of fat-soluble mycotoxins. In vitro studies showed
that CSM has a higher affinity to OTA than to bile salts, and some
animal experiments using CSM resulted in decreased plasma and
urine levels of OTA but also in an elevated OTA secretion in feces
(Hope, 2013).
The boosting of glutathione system may help in the
detoxification process. As the detoxification capacity of liver
varies with age, sex, and other factors, only boosting this
detoxification system is not enough in the neutralization of
mycotoxins. Other substances, like Vitamin C, E, D, or Q10
with zinc, could also help to prevent the harmful effects of
ROS. Unfortunately, these materials are not specific, and their
mechanism of action is based on the reduction of free radicals
(Rea et al., 2009; Hope, 2013). Dialysis and other supplementary
procedures to aid and protect the affected organs like the liver and
bone marrow may also help.
The efficiency of the diagnosis of chronic mycotoxicoses
is still low. The symptoms are non-specific and can be
easily mistaken for other diseases. Without further clinical
investigations, it is thus hard or nearly impossible to differentiate
between mycotoxicoses and other diseases. The course of the
disease may be modified when Kwashiorkor or other harmful
effects such as alcohol are present or the mycotoxin intake
is fluctuating. In chronic poisoning, the identification of the
different mycotoxins in any feed and food is also difficult,
because of the unknown time window of the poisoning. The
termination of mycotoxin intake from the food chain and an
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adequate nutrition can reduce the symptoms considerably in a
short period of time. Complementary medical procedures should
aid the damaged organs (Yilmaz et al., 2017), and liver or bone
marrow transplantation may also be taken into consideration,
when the affected organ is completely destroyed. The direct
administration of T leukocyte cultures has been hypothesized to
have a significant effect (Rea et al., 2009). However, the above
mentioned possibilities of treatment are hard to propagate due
to their complexity and high costs.
CONCLUDING REMARKS
The presence of mycotoxins in the feed and food chain has been a
widespread problem since the beginning of human history. In the
past, our possibilities to prevent or treat mycotoxin poisonings
were rather limited. Today, with our current knowledge and
technical capabilities, we are able to select and use highly efficient,
verified methods to mitigate the deleterious effects of mold
infestations. However, there are some newly emerging difficulties
on the horizon of a mycotoxin free agriculture. The geographical
border for harmful mold species like the toxigenic species in the
Aspergillus genus is moving north as a clear-cut consequence
of climate change. The possibility of mold infestations will rise
and the size of the affected territory will drastically increase
in the near future. To minimize agricultural, economical, and
medical risks set by spreading mycotoxins, it will be essential
to find a solution for the early detection and the prevention of
mycotoxin contaminations. Obviously, there are possibilities to
respond to these challenges adequately, but the ideal long-term
solution would be a pipeline, which is accepted and followed with
independent authorities worldwide to regulate and synchronize
the joint community efforts in combating mycotoxins.
Genetically engineered crops could help us to fight off mold
infestations even before mycotoxin contaminations have started.
Cheap and reliable analytical methods are needed for the early
and reliable detection of mycotoxins. The risk of mycotoxins
on human health and economy could be neutralized with
low-cost detoxification protocols, the implementation of which
would require a minimal technical background. The continuous
monitoring of storage and processing facilities is also a necessity.
The production of foodstuffs with ingredients from different
countries should be checked not only in the country where the
primary commodity was produced but also in the destination
countries once the final product is released into the market.
Exposures to multiple mycotoxins may lead to unforeseen
toxicological consequences and symptoms, which are currently
not known or not investigated yet.
In summary, mycotoxicoses may be a much bigger threat to
human health than they currently seem to be. For example, the
exact number of people suffering from any kind of acute or
chronic mycotoxin poisonings is almost impossible to calculate,
and the long-lasting adverse effects of chronic mycotoxin
exposures on human health have not been fully realized yet.
The carcinogenic effects and developmental disorders might
not be the most dangerous features of the Aspergillus-derived
mycotoxins because they can contribute considerably to human
infertility as well. Hence, the impacts of mycotoxins on future
generations can be even more significant than we thought before.
The increasing frequency of mycotoxin contaminations and the
astonishing complexity and variability of multiple mycotoxin
exposures might have severe and, at least in part, still hidden
effects on public health. Nevertheless, the best time to act should
be well before the mycotoxin-related problems have become
uncontrollable because prevention is always better and cheaper
than to cure an already manifested disease.
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